Full-Time

Scientist II

Editas Medicine

Editas Medicine

201-500 employees

Clinical stage genome editing for disease treatment

Biotechnology

Senior, Expert

Cambridge, MA, USA

Requirements
  • In depth knowledge of assay development for biologics including separation sciences (HPLC/UPLC), isoelectric focusing (icIEF), capillary electrophoresis (CE-SDS) and light scattering methods (MALS/DLS)
  • Demonstrated experience with independent method development and complex study design
  • Experience with mass spectrometry (ESI-MS, intact and peptide map) is preferred but not required
  • Experience with technical transfer of GMP test methods for biologics
  • Innovative & collaborative with the ability to multi-task, problem-solve, prioritize assignments, and adjust priorities to meet goals
  • Strong interpersonal, verbal, and written communication skills and knowledge of CRISPR gene editing technology
  • PhD in a life science discipline such as Biological Sciences, Biotechnology, Pharmaceutical Sciences, or Biomedical Engineering with 2+ years of relevant analytical development experience. Bachelors in a life science discipline such as Biological Sciences, Biotechnology, Pharmaceutical Sciences, or Biomedical Engineering with 12+ years of relevant analytical development and tech transfer experience or a Masters with 4+ years of experience
Responsibilities
  • Develop, optimize, and implement biophysical assays to support process development & process characterization to drive late-stage activities towards BLA
  • Design and execute forced degradation, stability, impurity identification and characterization studies
  • Lead the technical transfer of assays to Quality Control or central testing laboratories and provide SME support as needed
  • Compile and present data and assist in authoring and reviewing of test methods, technical reports, and protocols
  • Cross-train personnel on various biophysical assays, as required, and provide guidance to junior research associates
  • Document all experimental work, supporting information, and data in an electronic lab notebook (eLN) in a timely manner

Company Stage

N/A

Total Funding

$884.6M

Headquarters

Cambridge, Massachusetts

Founded

2013

Growth & Insights
Headcount

6 month growth

11%

1 year growth

19%

2 year growth

11%
INACTIVE